BrightSpring Health Services, Inc. (BTSG)
NASDAQ: BTSG · Real-Time Price · USD
35.79
+0.63 (1.79%)
At close: Dec 5, 2025, 4:00 PM EST
36.00
+0.21 (0.59%)
After-hours: Dec 5, 2025, 7:51 PM EST
BTSG Stock Forecast
Stock Price Forecast
According to 8 professional analysts, the 12-month price target for BTSG stock ranges from a low of $27 to a high of $42. The average analyst price target of $35.5 forecasts a -0.81% decrease in the stock price over the next year.
Price Target: $35.50 (-0.81%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for BTSG stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 3 | 3 | 3 | 3 |
| Buy | 4 | 4 | 4 | 4 | 5 | 5 |
| Hold | 1 | 1 | 1 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 8 | 7 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BMO Capital | BMO Capital | Buy Initiates $40 | Buy | Initiates | $40 | +11.76% | Nov 13, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $33 → $39 | Buy | Maintains | $33 → $39 | +8.97% | Nov 12, 2025 |
| BTIG | BTIG | Strong Buy Maintains $30 → $41 | Strong Buy | Maintains | $30 → $41 | +14.56% | Oct 29, 2025 |
| UBS | UBS | Strong Buy Maintains $35 → $42 | Strong Buy | Maintains | $35 → $42 | +17.35% | Oct 29, 2025 |
| Mizuho | Mizuho | Buy Maintains $26 → $32 | Buy | Maintains | $26 → $32 | -10.59% | Oct 17, 2025 |
Financial Forecast
Revenue This Year
12.99B
from 11.27B
Increased by 15.27%
Revenue Next Year
14.82B
from 12.99B
Increased by 14.10%
EPS This Year
1.08
from -0.09
EPS Next Year
1.36
from 1.08
Increased by 25.92%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 13.6B | 16.0B | |||
| Avg | 13.0B | 14.8B | |||
| Low | 12.4B | 13.7B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 20.3% | 23.0% | |||
| Avg | 15.3% | 14.1% | |||
| Low | 10.0% | 5.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.20 | 1.67 | |||
| Avg | 1.08 | 1.36 | |||
| Low | 0.98 | 1.02 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | 54.2% | |||
| Avg | - | 25.9% | |||
| Low | - | -5.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.